Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Choucha Z"'
Autor:
Brunet J; Institut Pasteur, Université Paris Cité, Département de Santé Globale, Paris, France., Choucha Z; Institut Pasteur, Université Paris Cité, Département de Santé Globale, Paris, France., Gransagne M; Institut Pasteur, Université Paris Cité, Département de Santé Globale, Paris, France., Tabbal H; Institut Pasteur, Université Paris Cité, CNRS UMR3569, Génétique Moléculaire des Virus à ARN, Paris, France., Ku M-W; Institut Pasteur, Université Paris Cité, Pasteur-TheraVectys Joint Lab, Paris, France., Buchrieser J; Institut Pasteur, Université Paris Cité, CNRS UMR3569, Virus and Immunity Unit, Paris, France., Fernandes P; Institut Pasteur, Université Paris Cité, INSERM U1223, Innate Immunity Unit, Paris, France., Batalie D; Institut Pasteur, Université Paris Cité, CNRS UMR3569, Génétique Moléculaire des Virus à ARN, Paris, France., Lopez J; Institut Pasteur, Université Paris Cité, Pasteur-TheraVectys Joint Lab, Paris, France., Ma L; Institut Pasteur, Université Paris Cité, Biomics, C2RT, Paris, France., Dufour E; Institut Pasteur, Université Paris Cité, CNRS UMR 3528, Production and Purification of Recombinant Proteins Technological Platform, Paris, France., Simon E; Institut Pasteur, Université Paris Cité, CNRS UMR3569, Génétique Moléculaire des Virus à ARN, Paris, France., Hardy D; Institut Pasteur, Université Paris Cité, Histopathology Platform, Paris, France., Petres S; Institut Pasteur, Université Paris Cité, CNRS UMR 3528, Production and Purification of Recombinant Proteins Technological Platform, Paris, France., Guinet F; Institut Pasteur, Université Paris Cité, INSERM U1223, Lymphocytes and Immunity Unit, Paris, France., Strick-Marchand H; Institut Pasteur, Université Paris Cité, INSERM U1223, Innate Immunity Unit, Paris, France., Monot M; Institut Pasteur, Université Paris Cité, Biomics, C2RT, Paris, France., Charneau P; Institut Pasteur, Université Paris Cité, Pasteur-TheraVectys Joint Lab, Paris, France., Majlessi L; Institut Pasteur, Université Paris Cité, Pasteur-TheraVectys Joint Lab, Paris, France., Duprex WP; Center for Vaccine Research, Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Gerke C; Institut Pasteur, Université Paris Cité, Innovation Office, Vaccine Programs, Paris, France., Martin A; Institut Pasteur, Université Paris Cité, CNRS UMR3569, Génétique Moléculaire des Virus à ARN, Paris, France., Escriou N; Institut Pasteur, Université Paris Cité, Département de Santé Globale, Paris, France.
Publikováno v:
Journal of virology [J Virol] 2024 May 14; Vol. 98 (5), pp. e0169323. Date of Electronic Publication: 2024 Apr 02.
Autor:
Launay O; Université de Paris, CIC Cochin-Pasteur; APHP, Hôpital Cochin; INSERM CIC1417, Paris, France., Artaud C; Institut Pasteur, Université de Paris, Centre de Recherche Translationnelle, Paris, France., Lachâtre M; Université de Paris, CIC Cochin-Pasteur; APHP, Hôpital Cochin; INSERM CIC1417, Paris, France., Ait-Ahmed M; Institut Pasteur, Université de Paris, Centre de Recherche Translationnelle, Paris, France., Klein J; SGS, Clinical Pharmacology Unit, Antwerpen, Belgium., Luong Nguyen LB; Université de Paris, CIC Cochin-Pasteur; APHP, Hôpital Cochin; INSERM CIC1417, Paris, France., Durier C; INSERM, SC10-US019, Villejuif, France., Jansen B; SGS, Mechelen, Belgium., Tomberger Y; Themis Bioscience GmbH, Vienna, Austria, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, United States., Jolly N; Institut Pasteur, Université de Paris, Centre de Recherche Translationnelle, Paris, France., Grossmann A; Themis Bioscience GmbH, Vienna, Austria, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, United States., Tabbal H; Institut Pasteur, Université de Paris, CNRS UMR3569, Génétique Moléculaire des Virus à ARN, Paris, France., Brunet J; Institut Pasteur, Université de Paris, Département de Santé Globale, Paris, France., Gransagne M; Institut Pasteur, Université de Paris, Département de Santé Globale, Paris, France., Choucha Z; Institut Pasteur, Université de Paris, Département de Santé Globale, Paris, France., Batalie D; Institut Pasteur, Université de Paris, CNRS UMR3569, Génétique Moléculaire des Virus à ARN, Paris, France., Delgado A; Bioaster, Lyon, France., Müllner M; Themis Bioscience GmbH, Vienna, Austria, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, United States., Tschismarov R; Themis Bioscience GmbH, Vienna, Austria, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, United States., Berghmans PJ; SGS, Clinical Pharmacology Unit, Antwerpen, Belgium., Martin A; Institut Pasteur, Université de Paris, CNRS UMR3569, Génétique Moléculaire des Virus à ARN, Paris, France., Ramsauer K; Themis Bioscience GmbH, Vienna, Austria, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, United States., Escriou N; Institut Pasteur, Université de Paris, Département de Santé Globale, Paris, France. Electronic address: nicolas.escriou@pasteur.fr., Gerke C; Institut Pasteur, Université de Paris, Innovation Office, Vaccine Programs, Paris, France. Electronic address: christiane.gerke@pasteur.fr.
Publikováno v:
EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103810. Date of Electronic Publication: 2022 Jan 16.
Autor:
Anna F; Theravectys, Paris, France., Goyard S; Unit of Lymphocyte Cell Biology, Immunology Department, Institut Pasteur, Paris, France.; INSERM 1221, Institut Pasteur, Paris, France., Lalanne AI; Laboratoire d'Immunologie Clinique, Institut Curie, Paris, France.; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France., Nevo F; Theravectys, Paris, France., Gransagne M; Innovation Laboratory: Vaccines, Institut Pasteur, Paris, France., Souque P; Unit of Molecular Virology and Vaccinology, Virology Department, Institut Pasteur, Paris, France., Louis D; Laboratoire d'Immunologie Clinique, Institut Curie, Paris, France.; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France., Gillon V; Direction of the Clinical Research, Institut Curie, Paris, France., Turbiez I; Direction of the Clinical Research, Institut Curie, Paris, France., Bidard FC; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France.; Medical Oncology Department, Institut Curie, Paris, France.; UVSQ, Paris-Saclay University, Saint-Cloud, France., Gobillion A; Biometry, Institut Curie, Paris, France., Savignoni A; Biometry, Institut Curie, Paris, France., Guillot-Delost M; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France.; INSERM U932, PSL University, Institut Curie, Paris, France., Dejardin F; Production and Purification of Recombinant Proteins Technological Platform, Institut Pasteur, Paris, France., Dufour E; Production and Purification of Recombinant Proteins Technological Platform, Institut Pasteur, Paris, France., Petres S; Production and Purification of Recombinant Proteins Technological Platform, Institut Pasteur, Paris, France., Richard-Le Goff O; Unit of Antibody in Therapy and Pathology, Institut Pasteur, Paris, France., Choucha Z; Innovation Laboratory: Vaccines, Institut Pasteur, Paris, France., Helynck O; Unit of Chemistry and Biocatalysis, Institut Pasteur, CNRS UMR 3523, Paris, France., Janin YL; Unit of Chemistry and Biocatalysis, Institut Pasteur, CNRS UMR 3523, Paris, France., Escriou N; Innovation Laboratory: Vaccines, Institut Pasteur, Paris, France., Charneau P; Theravectys, Paris, France.; Unit of Molecular Virology and Vaccinology, Virology Department, Institut Pasteur, Paris, France., Perez F; Cell Biology and Cancer Unit, Institut Curie, CNRS UMR 144, PSL Research University, Paris, France., Rose T; Unit of Lymphocyte Cell Biology, Immunology Department, Institut Pasteur, Paris, France.; INSERM 1221, Institut Pasteur, Paris, France., Lantz O; Laboratoire d'Immunologie Clinique, Institut Curie, Paris, France.; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France.; INSERM U932, PSL University, Institut Curie, Paris, France.
Publikováno v:
European journal of immunology [Eur J Immunol] 2021 Jan; Vol. 51 (1), pp. 180-190. Date of Electronic Publication: 2020 Dec 23.
Autor:
Boumaiza M; Laboratory of Molecular Microbiology, Vaccinology and Biotechnology Development, Group of Biotechnology Development, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis, Tunisia., Trabelsi K; Laboratory of Molecular Microbiology, Vaccinology and Biotechnology Development, Group of Biotechnology Development, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis, Tunisia.; Life Science Department, Biotechnology Programme, College of Graduate Studies, Arabian Gulf University, Manama, Bahrain., Choucha Z; Laboratory of Molecular Microbiology, Vaccinology and Biotechnology Development, Group of Biotechnology Development, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis, Tunisia., Akrouti I; Laboratory of Molecular Microbiology, Vaccinology and Biotechnology Development, Group of Biotechnology Development, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis, Tunisia., Leone S; Department of Chemical Sciences, University of Naples Federico II, Naples, Italy., Picone D; Department of Chemical Sciences, University of Naples Federico II, Naples, Italy., Kallel H; Laboratory of Molecular Microbiology, Vaccinology and Biotechnology Development, Group of Biotechnology Development, Institut Pasteur de Tunis, Université Tunis El Manar, Tunis, Tunisia.; UnivercellsVaccines, Nivelles, Belgium.
Publikováno v:
Preparative biochemistry & biotechnology [Prep Biochem Biotechnol] 2021; Vol. 51 (6), pp. 562-569. Date of Electronic Publication: 2020 Oct 23.
Autor:
Bahlawan, Omar, Badra, Rebecca, Semaan, Hanna, Fayad, Nancy, Kamel, Mina Nabil, El Taweel, Ahmed N., Gomaa, Mokhtar R., Sirawan, Abeer, Berry, Atika, Mokhbat, Jacques, Goldstein, Jimi, Abdallah, Jad, Kayali, Ghazi
Publikováno v:
Archives of Virology; Jul2022, Vol. 167 Issue 7, p1509-1519, 11p
Autor:
Loughran ST; Department of Life and Health Sciences, School of Health and Science, Dundalk Institute of Technology, Dundalk, Louth, Ireland. sinead.loughran@dkit.ie., Walls D; School of Biotechnology, Dublin City University, Dublin, Ireland.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2699, pp. 97-123.
Autor:
Mohamed Boumaiza, Ines Akrouti, Delia Picone, Héla Kallel, Khaled Trabelsi, Serena Leone, Zeineb Choucha
Hepatitis E virus (HEV) is a nonenveloped virus causing an emerging zoonotic disease posing a severe threat to the public health in the world, especially to pregnant women. In this study, a truncated form (aa 368-606) of the open reading frame 2 of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a4194ae7ee584484b7c281bc935716
http://hdl.handle.net/11588/830707
http://hdl.handle.net/11588/830707
